OpenAlex
PricingAboutJobs
Log inGet started
Work

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-09-1696
Authors: Lucy Lee, Huifeng Niu, Ruediger Rueger, Yuriko Igawa, Jonathan Deutsch, Nobuya Ishii, Song Mu, Yuuichiro Sakamoto, Rachel Busse-Reid, Claude Gimmi, Petra Goelzer, Stefanie De Schepper, Yashushi Yoshimura, Joanne Barrett, Yuji Ishikawa, Georges Weissgerber, Richard Peck
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: MEK inhibitors, MEK1/2 inhibition, PERK phosphorylation, pharmacokinetics, pharmacodynamics, safety and tolerability, single oral dose, healthy volunteers, pharmacokinetic-pharmacodynamic relationship, MAPK signaling, peripheral blood mononuclear cells, dose proportionality
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2081122128
FWCI: 1.589
Cites: 10
Cited by: 41
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security